SEC Form 4 · accession 0001424422-17-000002
BioPharmX Corp · BPMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles Gregory Vontz
Director
Period of report
Jan 18, 2017
Accepted (ET)
Jan 20, 2017 · 6:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001504167
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase common stockF1 | $0.45 | Jan 18, 2017 | A | 65,000 | A | Feb 18, 2017 | Jan 18, 2027 | Common stock | 65,000 | 65,000 | D |
| Option to purchase common stockF2 | $0.45 | Jan 18, 2017 | A | 60,000 | A | Feb 18, 2017 | Jan 18, 2027 | Common stock | 60,000 | 60,000 | D |
Explanation of responses
- F1This option vests ratably over 24 months with the first vesting starting on 2/18/17.
- F2This option vests ratably over 6 months with the first vesting starting on 2/18/17.